Terns Pharmaceuticals, Inc. (TERN)
May 5, 2026 - TERN was delisted (reason: acquired by MRK)
52.95
+0.02 (0.04%)
Inactive · Last trade price on May 4, 2026
Terns Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
59
Market Cap
6.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 1.00M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionTERN News
- 19 days ago - Merck Completes Acquisition of Terns Pharmaceuticals, Inc. - Business Wire
- 27 days ago - Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia - GlobeNewsWire
- 4 weeks ago - Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc. - Business Wire
- 5 weeks ago - Are TERN, SLNO, WSR Obtaining Fair Deals for their Shareholders? - PRNewsWire
- 6 weeks ago - Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc. - Business Wire
- 7 weeks ago - Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 7 weeks ago - Terns Pharmaceuticals Annual report: Q4 2025 - Filings
- 2 months ago - Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline - CNBC